HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 1,045-1,056 of 1,979
Other study type icon
CompletedNCT02746367

Bipolar Proteomic Assay Validation Study

Official study title

A Validation Study to Measure the Impact of a Proteomic Assay in Distinguishing Bipolar I Disorder, Bipolar II Disorder, and Major Depressive Disorder in People Presenting With a Major Depressive Episode

This study has finished and is no longer accepting participants.

Multiple locations, including Iowa City
Bipolarity, DepressionObservational studyAges 18–70
Countries
United States
Sponsor
Myriad Genetic Laboratories, Inc.
Device study icon
TerminatedNCT02839798

NeoSync TMS Treatment for Bipolar I Depression

Official study title

Evaluation of NeoSync EEG Synchronized TMS For the Treatment of Major Depressive Episode in Bipolar Disorder and Associated Neural Response: An Open Label Trial

This study ended early.

In Providence
Bipolarity, DepressionDevice studyAges 18–70
Countries
United States
Sponsor
Butler Hospital
Drug study icon
CompletedNCT00223496

12- Week Open Label Treatment of Refractory Depression in bipolarity

Official study title

12- Week Open Label Treatment of Refractory Bipolar Depression (BD) With Combination of Depakote ER (DEP) and Aripiprazole (AZP)

This study has finished and is no longer accepting participants.

In San Antonio
Bipolarity, DepressionMedication studyAges 18–75
Countries
United States
Sponsor
The University of Texas Health Science Center at San Antonio
Drug study icon
CompletedNCT04235686

8 Week Multi-site Study of MYDAYIS® for Depression in bipolarity

Official study title

An 8 Week Randomized Double Blind Placebo Controlled Multi-site Study Assessing Efficacy and Safety of MYDAYIS® (D-amphetamine / L-amphetamine) for Bipolar Depression

This study has finished and is no longer accepting participants.

Multiple locations, including Rochester
Bipolarity, DepressionMedication studyAges 18–55
Countries
United States
Sponsor
Mayo Clinic
Drug study icon
CompletedNCT03379597

Dietary Fiber and Probiotics Treatment for schizophrenia

Official study title

A 12-weeks Study to Evaluate the Dietary Fiber and Probiotics Treatment in Prevention and Intervention of Weight-gain and Cognitive Impairment of Schizophrenia or Bipolar Disorder

This study has finished and is no longer accepting participants.

In Changsha
Bipolarity, SchizophreniaMedication studyAges 18–65
Countries
China
Sponsor
Central South University

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.